# Bioequivalence Between Two Oral Nicotine Sublingual Tablets, 2 mg and 4 mg

> **NCT01238627** · NA · COMPLETED · sponsor: **McNeil AB** · enrollment: 40 (actual)

## Conditions studied

- Tobacco Dependence

## Interventions

- **DRUG:** Nicotine Sublingual Tablet Mint (NSTM)
- **DRUG:** Marketed Nicotine Tablet

## Key facts

- **NCT ID:** NCT01238627
- **Lead sponsor:** McNeil AB
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2012-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01238627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01238627, "Bioequivalence Between Two Oral Nicotine Sublingual Tablets, 2 mg and 4 mg". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01238627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*